|
|
|
|
|
27.02.26 - 14:48
|
ANLEIHEN-Woche #KW9 – 2026: Photon Energy, HomeToGo, PANDION, Underberg, BENO, DN Group, BOOSTER, LR, EPH, Pferdewetten, HÖRMANN, AREAM, ESPG, … (Anleihen-Finder)
|
|
|
Marktgeschehen in der letzten Februar-Woche Die HomeToGo SE platziert in der KW9 erfolgreich einen vorrangig besicherten fünfjährigen Nordic Bond über 101 Mio. Euro mit variablem […]
Der Beitrag ANLEIHEN-Woche #KW9 – 2026: Photon Energy, HomeToGo, PANDION, Underberg, BENO, DN Group, BOOSTER, LR, EPH, Pferdewetten, HÖRMANN, AREAM, ESPG, … erschien zuerst auf Anleihen-Finder.de....
|
|
|
|
|
|
|
|
|
|
|
10.02.26 - 20:49
|
AI Spending is Surging, but Consumers are Slowing | Open Interest 2/10/2026 (Bloomberg)
|
|
|
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Global AI spending is surging as Alphabet raises billions in a massive bond deal. And new retail data shows US consumers are starting to pull back. Meanwhile, investors are navigating a flood of earnings, from Coca-Cola's challenges to Ferrari's red-hot demand. Plus, how AI could dramatically speed up drug trials — and what extreme winter weather means for the durability of America's power grid. We talk to Harry Sideris, the CEO of Duke Energy. (Source: Bloomberg)...
|
|
|
10.02.26 - 17:01
|
AI Spending is Surging, but Consumers are Slowing (Bloomberg)
|
|
|
Global AI spending is surging as Alphabet raises billions in a massive bond deal. And new retail data shows US consumers are starting to pull back. Meanwhile, investors are navigating a flood of earnings, from Coca-Cola's challenges to Ferrari's red-hot demand. Plus, how AI could dramatically speed up drug trials — and what extreme winter weather means for the durability of America's power grid. We talk to Harry Sideris, the CEO of Duke Energy. (Source: Bloomberg)...
|
|
|
02.02.26 - 07:45
|
SAP schmiert ab, E.ON klettert weiter: DAX-Ausblick (Sharedeals)
|
|
|
Der DAX ist in der vergangenen Woche weiter zurückfallen. Unter dem Strich büßte das größte deutsche Börsenbarometer knapp 362 Punkte ein und schloss -1,45% tiefer mit 24.538 Punkten. Die höchsten Verluste gab es bei SAP und Airbus, E.ON war bester Wert im DAX. Wie geht es in der neuen Woche weiter? SAP sorgt für tiefroten […]
The post SAP schmiert ab, E.ON klettert weiter: DAX-Ausblick first appeared on sharedeals.de....
|
|
|
19.01.26 - 17:48
|
FR Regulatory News: Charwood Energy (EQS)
|
|
|
Charwood Energy: Energy&+ to produce a hot water loop as part of the ENGIE Solutions offer for the decarbonization of the Stellantis La Janais site...
|
|
|
14.01.26 - 15:03
|
Exelon Announces Additional $10 Million Contribution to Customer Relief Fund, Supporting Customers as Winter Weather Drives Higher Energy Use (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Exelon (Nasdaq: EXC) today announced an additional $10 million contribution to its Customer Relief Fund, strengthening support for communities as cold weather drives up energy demand and costs remain high.
The contribution brings Exelon's direct customer assistance efforts to address energy affordability to $60 million in the past year. Exelon does not control or profit from increasing energy supply costs, a key driver of increased costs on customer bills.
Each of Exelon's operating companies — Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO and Pepco — receive a portion of the contribution, which will be administered by trusted local nonprofits. Funding amounts, eligibility criteria, and delivery methods will vary by service territory to reflect local needs.
“People are frustrated by rising costs, and we share that frustration, especially as cold weather sets in,” said Exelon President and CEO Calvin Butler. “We're proud to step up and help in the short ter...
|
|
|
05.01.26 - 20:06
|
Exelon to Announce Fourth Quarter Results on Feb. 12 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Exelon (Nasdaq: EXC) will hold its fourth quarter 2025 earnings conference call at 9:00 a.m. CT / 10:00 a.m. ET on Thursday, Feb. 12, 2026. The conference call will be led by Exelon President and CEO, Calvin Butler, and Exelon Executive Vice President and CFO, Jeanne Jones.
To listen to or view the upcoming earnings presentation, please access the live listen-only webcast here. The audio webcast link will also be available on the Investor Relations page and will be archived and available for replay.
About Exelon
Exelon (Nasdaq: EXC) is a Fortune 200 company and one of the nation's largest utility companies, serving more than 10.7 million customers through six fully regulated transmission and distribution utilities — Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco. Exelon's 20,000 employees dedicate their time and expertise to supporting our communities through reliable, affordable and efficient energy delivery, workforce development, equity, economic devel...
|
|
|
|
|
|
|
19.12.25 - 15:01
|
E-Mobility-Unternehmen gründen neuen Branchenverband e-Mobility Deutschland e.V. (Electrive)
|
|
|
ABB E-mobility, Alpitronic, Aral Pulse (BP Europa), Electra, Engie Vianeo, Fastned, Ionity und Shell haben den Verband e-Mobility Deutschland e.V. gegründet. Zweck dieses neuen Verbands ist es, die Interessen der Elektromobilitätsbranche mit Fokus auf den Ausbau der Ladeinfrastruktur gegenüber Politik, Verwaltung und Öffentlichkeit zu vertreten....
|
|
|
|
|
|
|
16.12.25 - 19:15
|
Thorizon plant Schmelzsatzreaktor in den Niederlanden (Tichys Einblick)
|
|
|
Die Niederlande haben einen erstaunlichen Wandel in Sachen Kernenergie hingelegt. Vor wenigen Jahren war diese Technik noch verpönt. Der letzte Reaktor Borssele sollte 2004 abgeschaltet werden. Die Notwendigkeit, die CO2-Emissionen mit der Zeit auf Null zu reduzieren, führte stattdessen dazu, die Laufzeit des Reaktors, der weitgehend baugleich ist mit dem längst abgerissenen in Stade an
Der Beitrag Thorizon plant Schmelzsatzreaktor in den Niederlanden erschien zuerst auf Tichys Einblick....
|
|
|
05.12.25 - 15:03
|
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia and BOSTON, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced new data highlighting its commitment in epilepsy, including interim 48-month data from its ongoing X-TOLE open-label extension (OLE) study of azetukalner in patients with focal onset seizures (FOS), multiple real world studies on the burden of depression and anti-seizure medication (ASM) titration in epilepsy, and new data for its pre-clinical program in Dravet syndrome. These data are being presented at the American Epilepsy Society Annual Meeting (AES 2025), taking place December 5-9, 2025 in Atlanta, Georgia....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
